Cambridge Consultants To Showcase Inhaler Design And Development Process At RDD 2009, Europe
Main Category: Respiratory / AsthmaArticle Date: 18 May 2009 - 3:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Cambridge Consultants will be showcasing its proprietary design and development process for Dry Power Inhalers (DPIs) at the Respiratory Drug Delivery (RDD) Europe 2009 conference in Lisbon later this month. The company will demonstrate its ability to move inhaler design quickly through all stages of development from concept through manufacture to final product, getting it right first time, accelerating the creation of new inhalable drug delivery devices, and offering pharmaceutical companies a quick route to market, saving up to six months in development.
"Our RDD presence is all about the importance of speed to market, and this demonstration is designed to highlight the range of development capabilities we can deploy to achieve it for our clients," commented David Blakey, Head of Drug Delivery at Cambridge Consultants. "It is crucial to ensure process quality in stages such as concept creation, complex mathematical modelling and detailed design. These are areas where Cambridge Consultants adds significant value, based on our skill and experience in running turn key developments, from concept to clinical trial and through transfer to manufacture."
Cambridge Consultants will be using Gen-X, a proprietary DPI, to demonstrate the key stages in the design cycle. The display tracks the stages of the process up to the test bed stage, where the efficacy of the de-aggregation engine has been tested. Cambridge Consultants is currently selecting development partners to take this concept to market.
David Blakey adds: "Supported by our proprietary design and development process, our partners can cut up to six months off the development cycle for DPIs, giving them a significant head start and reducing development risk."
The demonstration of Cambridge Consultants' product development process will be available on Cambridge Consultants' stand at the Respiratory Drug Delivery Europe 2009 conference in Lisbon, Portugal, from 19-22 May.
Source
Cambridge Consultants
Visit our respiratory / asthma section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/150412.php>
APA
http://www.medicalnewstoday.com/releases/150412.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




